A new report from the Government Accountability Office (GAO) has found the federal response to antibiotic resistance is falling short in several areas.The GAO report, issued earlier this week, examined federal efforts related to surveillance of antibiotic resistant bacteria, the development and use of diagnostic tests to detect antibiotic resistance, the development of new antibiotics, and tracking appropriate antibiotic use. In all four areas, the GAO found that while progress has been made, the response to date from the Centers for Disease Control and Prevention (CDC) and the Department of Health and Human Services (HHS) has been hampered by several challenges.Among the challenges highlighted in the report are limited data and lack of timely information on the magnitude of and trends in antibiotic resistance, limited research on the value of diagnostic tests for reducing rates of antibiotic-resistant infections, lack of a strategy to incentivize development of new antibiotics, and a limited ability to monitor and improve antibiotic use in healthcare settings. Based on the findings, the GAO has made a series of recommendations to strengthen the federal response.

 

Credit: iStock, Fahroni

Read more at CIDRAP…